118 related articles for article (PubMed ID: 14580927)
1. Tolerance to the protective effect of salmeterol in mild untreated asthmatics.
Giannini D; Di Franco A; Bacci E; Dente FL; Vagaggini B; Taccola M; Tonelli M; Zingoni M; Paggiaro P
Pulm Pharmacol Ther; 2003; 16(6):355-60. PubMed ID: 14580927
[TBL] [Abstract][Full Text] [Related]
2. Inhaled beclomethasone dipropionate reverts tolerance to the protective effect of salmeterol on allergen challenge.
Giannini D; Bacci E; Dente FL; Di Franco A; Vagaggini B; Testi R; Paggiaro P
Chest; 1999 Mar; 115(3):629-34. PubMed ID: 10084467
[TBL] [Abstract][Full Text] [Related]
3. Tolerance to the protective effect of salmeterol on allergen challenge can be partially restored by the withdrawal of salmeterol regular treatment.
Giannini D; Di Franco A; Bacci E; Dente FL; Bartoli ML; Vagaggini B; Paggiaro P
Chest; 2001 Jun; 119(6):1671-5. PubMed ID: 11399689
[TBL] [Abstract][Full Text] [Related]
4. Tolerance to the protective effect of salmeterol on allergen challenge.
Giannini D; Carletti A; Dente FL; Bacci E; Di Franco A; Vagaggini B; Paggiaro PL
Chest; 1996 Dec; 110(6):1452-7. PubMed ID: 8989060
[TBL] [Abstract][Full Text] [Related]
5. Minimal tolerance to the bronchoprotective effect of inhaled salmeterol/fluticasone combination on allergene challenge.
Paggiaro PL; Giannini D; Di Franco A; Bacci E; Dente FL; Vagaggini B; Tonelli M; Zingoni M
Pulm Pharmacol Ther; 2006; 19(6):425-9. PubMed ID: 16326121
[TBL] [Abstract][Full Text] [Related]
6. Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses.
Pizzichini MM; Kidney JC; Wong BJ; Morris MM; Efthimiadis A; Dolovich J; Hargreave FE
Eur Respir J; 1996 Mar; 9(3):449-55. PubMed ID: 8730003
[TBL] [Abstract][Full Text] [Related]
7. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
Kalra S; Swystun VA; Bhagat R; Cockcroft DW
Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
[TBL] [Abstract][Full Text] [Related]
9. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol.
Lipworth BJ; Aziz I
J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190
[TBL] [Abstract][Full Text] [Related]
10. Effect of short- and long-acting inhaled beta2-agonists on exhaled nitric oxide in asthmatic patients.
Yates DH; Kharitonov SA; Barnes PJ
Eur Respir J; 1997 Jul; 10(7):1483-8. PubMed ID: 9230234
[TBL] [Abstract][Full Text] [Related]
11. Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects.
Dente FL; Bancalari L; Bacci E; Bartoli ML; Carnevali S; Cianchetti S; Di Franco A; Giannini D; Vagaggini B; Testi R; Paggiaro PL
Thorax; 1999 Jul; 54(7):622-4. PubMed ID: 10377209
[TBL] [Abstract][Full Text] [Related]
12. Tolerance to the protective effects of salmeterol on methacholine-induced bronchoconstriction: influence of inhaled corticosteroids.
Boulet LP; Cartier A; Milot J; Côté J; Malo JL; Laviolette M
Eur Respir J; 1998 May; 11(5):1091-7. PubMed ID: 9648961
[TBL] [Abstract][Full Text] [Related]
13. Protection against allergen-induced asthma by salmeterol.
Twentyman OP; Finnerty JP; Harris A; Palmer J; Holgate ST
Lancet; 1990 Dec; 336(8727):1338-42. PubMed ID: 1978163
[TBL] [Abstract][Full Text] [Related]
14. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
15. Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism.
Lipworth BJ; Dempsey OJ; Aziz I
Chest; 2000 Aug; 118(2):321-8. PubMed ID: 10936119
[TBL] [Abstract][Full Text] [Related]
16. Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.
Simons FE; Gerstner TV; Cheang MS
Pediatrics; 1997 May; 99(5):655-9. PubMed ID: 9113940
[TBL] [Abstract][Full Text] [Related]
17. The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X.
Pedersen B; Dahl R; Larsen BB; Venge P
Allergy; 1993 Jul; 48(5):377-82. PubMed ID: 8103646
[TBL] [Abstract][Full Text] [Related]
18. Effects of theophylline on tolerance to the bronchoprotective actions of salmeterol in asthmatics in vivo.
Cheung D; Wever AM; de GOEIJ JA; de GRAAFF CS; Steen H; Sterk PJ
Am J Respir Crit Care Med; 1998 Sep; 158(3):792-6. PubMed ID: 9731006
[TBL] [Abstract][Full Text] [Related]
19. Salmeterol does not alter increased bronchial responsiveness caused by organic dust exposure.
Ek A; Palmberg L; Sundblad BM; Larsson K
Chest; 2005 Oct; 128(4):3038-47. PubMed ID: 16236984
[TBL] [Abstract][Full Text] [Related]
20. Dose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma.
Higham MA; Sharara AM; Wilson P; Jenkins RJ; Glendenning GA; Ind PW
Thorax; 1997 Nov; 52(11):975-80. PubMed ID: 9487346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
